Showing items related by title, author, creator and subject.

• Registration of Drugs for Treating Cancer and HIV Infection: A Plea to Carry Out Phase 3 Trials Before Admission to the Market 

  Koopmans, P.P. (1995-05-20)

  Drugs for cancer and HIV infection tend to be admitted to the market on the basis of results from phase 2 trials. Assessing the benefit-risk balance with phase 2 trials often is difficult -- the effect of the drug is usually ...